Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Held

Showing results (61-70 of 108) with videos related to

Pageof 11
Sort By:
Thrombosis and Haemostasis|March 25, 2016
Home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban. Rationale and design of the HoT-PE TrialStefano Barco, Mareike Lankeit, Harald Binder, et al.
Pulmonary Circulation|June 10, 2017
The safety and pharmacokinetics of rapid iloprost aerosol delivery via the BREELIB nebulizer in pulmonary arterial hypertensionTobias Gessler, Hossein-Ardeschir Ghofrani, Matthias Held, et al.
Journal of Cardiovascular Development and Disease|October 26, 2022
Prognostic Relevance of Cardiopulmonary Exercise Testing for Patients with Chronic Thromboembolic Pulmonary HypertensionRalf Ewert, Till Ittermann, Delia Schmitt, et al.
International Journal of Cardiology|August 23, 2018
Pulmonary hypertension due to lung diseases: Updated recommendations from the Cologne Consensus Conference 2018Horst Olschewski, Jürgen Behr, Hinrich Bremer, et al.
Journal of Thrombosis and Haemostasis : JTH|December 25, 2025
Follow-up Algorithm for Detecting Chronic Sequelae of Pulmonary Embolism: Diagnostic Performance and Possible LimitationsIoannis T Farmakis, Luca Valerio, Stefano Barco, et al.
Respiration; International Review of Thoracic Diseases|October 27, 2016
Safety, Tolerability and Clinical Effects of a Rapid Dose Titration of Subcutaneous Treprostinil Therapy in Pulmonary Arterial Hypertension: A Prospective Multi-Centre TrialEkkehard Grünig, Nicola Benjamin, Tobias J Lange, et al.
International Journal of Cardiology|January 7, 2012
Pulmonary hypertension due to chronic lung disease: updated Recommendations of the Cologne Consensus Conference 2011Marius M Hoeper, Stefan Andreas, Andreas Bastian, et al.
International Journal of Cardiology|September 17, 2018
Definition, clinical classification and initial diagnosis of pulmonary hypertension: Updated recommendations from the Cologne Consensus Conference 2018Gabor Kovacs, Daniel Dumitrescu, Andreas Barner, et al.
Frontiers in Immunology|September 2, 2022
COVID-19 patients share common, corticosteroid-independent features of impaired host immunity to pathogenic moldsBeeke Tappe, Chris D Lauruschkat, Lea Strobel, et al.
The European Respiratory Journal|October 20, 2018
Risk assessment in medically treated chronic thromboembolic pulmonary hypertension patientsMarion Delcroix, Gerd Staehler, Henning Gall, et al.
Pageof 11

Showing results (61-70 of 108) with videos related to

Sort By:
Pageof 11
Thrombosis and Haemostasis|March 25, 2016
Home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban. Rationale and design of the HoT-PE TrialStefano Barco, Mareike Lankeit, Harald Binder, et al.
Pulmonary Circulation|June 10, 2017
The safety and pharmacokinetics of rapid iloprost aerosol delivery via the BREELIB nebulizer in pulmonary arterial hypertensionTobias Gessler, Hossein-Ardeschir Ghofrani, Matthias Held, et al.
Journal of Cardiovascular Development and Disease|October 26, 2022
Prognostic Relevance of Cardiopulmonary Exercise Testing for Patients with Chronic Thromboembolic Pulmonary HypertensionRalf Ewert, Till Ittermann, Delia Schmitt, et al.
International Journal of Cardiology|August 23, 2018
Pulmonary hypertension due to lung diseases: Updated recommendations from the Cologne Consensus Conference 2018Horst Olschewski, Jürgen Behr, Hinrich Bremer, et al.
Journal of Thrombosis and Haemostasis : JTH|December 25, 2025
Follow-up Algorithm for Detecting Chronic Sequelae of Pulmonary Embolism: Diagnostic Performance and Possible LimitationsIoannis T Farmakis, Luca Valerio, Stefano Barco, et al.
Respiration; International Review of Thoracic Diseases|October 27, 2016
Safety, Tolerability and Clinical Effects of a Rapid Dose Titration of Subcutaneous Treprostinil Therapy in Pulmonary Arterial Hypertension: A Prospective Multi-Centre TrialEkkehard Grünig, Nicola Benjamin, Tobias J Lange, et al.
International Journal of Cardiology|January 7, 2012
Pulmonary hypertension due to chronic lung disease: updated Recommendations of the Cologne Consensus Conference 2011Marius M Hoeper, Stefan Andreas, Andreas Bastian, et al.
International Journal of Cardiology|September 17, 2018
Definition, clinical classification and initial diagnosis of pulmonary hypertension: Updated recommendations from the Cologne Consensus Conference 2018Gabor Kovacs, Daniel Dumitrescu, Andreas Barner, et al.
Frontiers in Immunology|September 2, 2022
COVID-19 patients share common, corticosteroid-independent features of impaired host immunity to pathogenic moldsBeeke Tappe, Chris D Lauruschkat, Lea Strobel, et al.
The European Respiratory Journal|October 20, 2018
Risk assessment in medically treated chronic thromboembolic pulmonary hypertension patientsMarion Delcroix, Gerd Staehler, Henning Gall, et al.
Pageof 11